Data / Form D filings / SeQure Dx Inc.
SeQure Dx Inc.: Form D filings
SeQure Dx Inc., a biotechnology company in Waltham, MA, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on December 22, 2023, reports $2.2 million sold of a $5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1440 MAIN STREET, Waltham, MA, 02451
- Phone
- (978) 828-1395
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1854843
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | New notice | $5,000,000 | $2,177,419 | $2,822,581 | 7 | Nov 21, 2023 | sec.gov |
| Dec 22, 2023 | New notice | $8,000,000 | $2,612,903 | $5,387,097 | 7 | Jun 22, 2023 | sec.gov |
| Apr 6, 2021 | New notice | $17,500,000 | $17,500,000 | 9 | Mar 24, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carl M. Berke | Director | |
| Isaac M. Zike | Director | |
| Sanjay Pothen | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 18, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SeQure Dx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.